Stay updated with breaking news from Inducement Options. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHILADELPHIA, Nov. 17, 2023 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced...
PHILADELPHIA, Oct. 20, 2023 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced...
PHILADELPHIA, April 21, 2023 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced... | April 21, 2023
20.01.2023 - PHILADELPHIA, Jan. 20, 2023 (GLOBE NEWSWIRE) - Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted ...
Appoints Timothy E. Morris, a veteran biotech executive with over 35 years of experience in executive and financial leadership, to Board of DirectorsNames...